Patent application number | Description | Published |
20080235058 | VITAL SIGN MONITOR UTILIZING HISTORIC PATIENT DATA - A vital sign monitoring system that can be used with multiple patients and utilizes historic patient data information for the patient to optimize the process of obtaining current vital sign measurements. Each patient is identified with a unique patient identification device that is automatically detected by the vital sign monitor. The vital sign monitor communicates with a medical records database and obtains historic patient data information and previously diagnosed characteristics for the patient identified by the patient identification device. The historic patient data information and previously diagnosed characteristics of the patient can be utilized by the vital sign monitor to set alarm limits for the vital sign measurements and automatically adjust the blood pressure estimation algorithm of the NIBP monitor. | 09-25-2008 |
20080262362 | NON-INVASIVE BLOOD PRESSURE DETERMINATION METHOD - A method for estimating systolic and diastolic pressure is disclosed herein. The method includes obtaining a predetermined type of blood pressure data from a patient, and providing previously acquired blood pressure data obtained from a plurality of different subjects. The method also includes implementing the previously acquired blood pressure data to select systolic and diastolic amplitude ratios that most closely correlate with the predetermined type of blood pressure data obtained from the patient. The selected systolic and diastolic amplitude ratios are adapted to compensate for the effects of arterial compliance. The method also includes implementing the selected systolic and diastolic amplitude ratios to generate a systolic and diastolic blood pressure estimates. | 10-23-2008 |
20090062663 | NON-INVASIVE BLOOD PRESSURE MONITOR APPARATUS AND SYSTEM - A non-invasive blood pressure monitoring system is disclosed herein. The non-invasive blood pressure monitoring system includes a pressure cuff comprising a resistive portion and a conductive portion aligned with the resistive portion. The non-invasive blood pressure monitoring system also includes a controller operatively connected to the pressure cuff. The controller is adapted to estimate the circumference of the pressure cuff based on the position of the conductive portion relative to the resistive portion. | 03-05-2009 |
20090177101 | METHOD OF FETAL AND MATERNAL ECG IDENTIFICATION ACROSS MULTIPLE EPOCHS - A method of utilizing maternal-fetal monitoring system to monitor the physiological properties of both a maternal patient and a fetus. The method places a series of ECG electrodes across the maternal patient's abdomen and receives ECG input waveforms across a plurality of separate channels. The method processes the channels using an ICA algorithm to generate a series of ICA output waveforms. The ICA output waveforms are analyzed for each individual epoch to determine which of the channels include a maternal signal or a fetal signal source. Based upon the determination of which channel includes the fetal and maternal signals, further processing is carried out on the ICA output waveform on the identified channel to obtain physiological properties for the patient and the fetus. During the next epoch, the same signal processing occurs, such that the system can identify the fetal and maternal signals even as the fetal and maternal jump channels from one epoch to another. | 07-09-2009 |
20090209874 | EXTRAPOLATING ICA KNOWLEDGE FROM ONE EPOCH TO ANOTHER FOR IMPROVED FETAL ECG SEPARATION - A method of utilizing a maternal-fetal monitoring system to monitor the physiological properties of both a maternal patient and a fetus. A series of ECG electrodes are placed across the maternal patient's abdomen and receives ECG input waveforms across sixteen separate channels. The sixteen channels of information are processed using an ICA algorithm to generate a series of ICA output waveforms and a transfer matrix. Following the current epoch, the transfer matrix is applied to the input waveforms on a continuous basis. The conditioned input waveforms are displayed immediately following the first epoch and prior to the expiration of a subsequent epoch. The transfer matrix for the second epoch is combined with the transfer matrix for the first epoch to generate an updated transfer matrix. Various filtering operations on the transfer matrix coefficients may be used to find the updated transfer matrix before the end of the current epoch. | 08-20-2009 |
20100063367 | VITAL SIGN MONITOR UTILIZING HISTORIC PATIENT DATA - A vital sign monitoring system that can be used with multiple patients and utilizes historic patient data information for the patient to optimize the process of obtaining current vital sign measurements. Each patient is identified with a unique patient identification device that is automatically detected by the vital sign monitor. The vital sign monitor communicates with a medical records database and obtains historic patient data information for the patient identified by the patient identification device. The historic patient data information can be utilized by the vital sign monitor to set alarm limits for the vital sign measurements and automatically control the operation of an NIBP monitor for the specific patient. | 03-11-2010 |
Patent application number | Description | Published |
20130302273 | COMPOSITIONS DERIVED FROM STEM CELL RELEASED MOLECULES & METHODS FOR FORMULATION THEREOF - Compositions for use in treatment of a variety of tissue diseases include stem cells and stem cell released molecules (SRM's) suspended in an aqueous solution with a cellulosic material or other thickening agent. The stem cells and SRM's can be derived from one or more distinct cell lines. The SRM's can further include one or more mucins, cytokines, or growth factors. Exemplary formulations include stem cells and SRMs derived from epithelial stem cells, corneal limbal stem cells, and fibroblasts. Other compositions and methods for formulation thereof are described. | 11-14-2013 |
20140205563 | COMPOSITIONS DERIVED FROM STEM CELL RELEASED MOLECULES & METHODS FOR FORMULATION THEREOF - Compositions for use in treatment of a variety of tissue diseases include stem cells and stem cell released molecules (SRM's) suspended in an aqueous solution with a cellulosic material or other thickening agent. The stem cells and SRM's can be derived from one or more distinct cell lines. The SRM's can further include one or more mucins, cytokines, or growth factors. Exemplary formulations include stem cells and SRMs derived from epithelial stem cells, corneal limbal stem cells, and fibroblasts. Other compositions and methods for formulation thereof are described. | 07-24-2014 |
20150071877 | BIOACTIVE COMPOSITIONS AND METHODS FOR THEIR PREPARATION AND USE - A method for preparing a bioactive composition containing conditioned cell culture medium is disclosed. The method comprises culturing cells of two or more eukaryotic cell line to form conditioned culture media, separating the cultured cells from the conditioned culture media, and combining conditioned culture media to form a bioactive composition. Novel bioactive compositions, formulations and their use in treating of a variety of diseases and health conditions are also disclosed. | 03-12-2015 |